Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to “email@example.com”, and happy to have you featured on our newsletter!
Clinerion is the worldwide leader in medical data informatics, radically improving efficiency in patient search and identification, increasing effectiveness in clinical research and accelerating the process of drug development to ensure an earlier availability of medicines.
Oryzon Genomics, a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the Board of Directors of the Alzheimer’s Drug Discovery Foundation has approved a grant of $1.5 million to Oryzon Genomics S.A. to support the US-arm of Oryzon’s ETHERAL Phase IIa clinical trial with vafidemstat in Alzheimer’s disease patients.
A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body. The new micro-device for fluid analysis just unveiled in Advanced Functional Materials will enable more tailored experiments in drug development and disease research.
The Pharmaceutical Society of Australia (PSA) today congratulates the re-elected Morrison Government and looks forward to working together to address medicine safety, negotiating the next Community Pharmacy Agreement and delivering better healthcare for all Australians.
Prof David Rubinsztein at the University of Cambridge has been awarded more than £500,000 from leading dementia research charity, Alzheimer’s Research UK. The new funding will support research into a way to tackle diseases like Alzheimer’s by boosting the brain’s waste disposal system.
FarmaKology is a newsletter that brings you the latest news, research, job opportunities in the Pharma world, and much more! If you would like to be featured in the newsletter, sponsor an issue, or need anything, please feel free to get in touch with me at "firstname.lastname@example.org".